ES2059666T3 - Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih. - Google Patents

Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih.

Info

Publication number
ES2059666T3
ES2059666T3 ES89118626T ES89118626T ES2059666T3 ES 2059666 T3 ES2059666 T3 ES 2059666T3 ES 89118626 T ES89118626 T ES 89118626T ES 89118626 T ES89118626 T ES 89118626T ES 2059666 T3 ES2059666 T3 ES 2059666T3
Authority
ES
Spain
Prior art keywords
hiv infection
treatment
catabolic enzymes
enzymes
catabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89118626T
Other languages
English (en)
Inventor
Karl Ransberger
Gerhard Dr Stauder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucos Emulsion GmbH
Original Assignee
Mucos Emulsion GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucos Emulsion GmbH filed Critical Mucos Emulsion GmbH
Application granted granted Critical
Publication of ES2059666T3 publication Critical patent/ES2059666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL INVENTO SE REFIERE A UNAS ENZIMAS CATABOLICAS, QUE SE ELIGEN ENTRE PANCREATICA, BROMELAINA, PAPAINA, LIPASA, AMILASA, TRIPSINA Y/O QUIMOTRIPSINA Y SE UTILIZAN PARA EL TRATAMIENTO DE INFECCIONES PRIMARIAS DE HIV.
ES89118626T 1989-10-06 1989-10-06 Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih. Expired - Lifetime ES2059666T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89118626A EP0421022B1 (de) 1989-10-06 1989-10-06 Verwendung katabolischer Enzyme zur Bekämpfung einer HIV-Erst-Infektion

Publications (1)

Publication Number Publication Date
ES2059666T3 true ES2059666T3 (es) 1994-11-16

Family

ID=8201994

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89118626T Expired - Lifetime ES2059666T3 (es) 1989-10-06 1989-10-06 Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih.

Country Status (4)

Country Link
EP (1) EP0421022B1 (es)
AT (1) ATE92331T1 (es)
DE (1) DE58905180D1 (es)
ES (1) ES2059666T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
NL9201842A (nl) * 1992-10-23 1994-05-16 Teng Hian Khoe Toepassing van een papaine bevattend voedingssupplement voor therapeutische behandeling van AIDS aandoeningen.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
ITFI20050098A1 (it) * 2005-05-10 2006-11-11 Domenico Acanfora Composizione farmaceutica per il trattamento della immunodeficienza acquisita
WO2011063394A2 (en) * 2009-11-23 2011-05-26 Olmstead Stephen F Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
DE102020207281A1 (de) 2020-06-10 2021-12-16 Helmholtz-Zentrum für Infektionsforschung GmbH für das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Extrakt aus dem Stamm und/oder der Frucht einer Ananas-Pflanze, Jacalin-ähnliches Lectin, Kombinationspräparat, Bromelain, Bromelain-Protease, Bromelain-Proteaseinhibitor, Protein-Proteasen-Gemisch, durch exogene nicht-enzymatische Glykation entstandenes glykiertes Bromelain-Protein zur Verwendung bei der Behandlung oder Prophylaxe von Virusinfektionen in einem Mensch oder Tier
DE102020004633A1 (de) 2020-06-10 2021-12-16 Helmholtz-Zentrum für Infektionsforschung GmbH für das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Bromelain-Protease zur Verwendung bei der Behandlung oder Prophylaxe von Virusinfektionen in einem Mensch oder Tier
DE102020004632A1 (de) 2020-06-10 2021-12-16 Helmholtz-Zentrum für Infektionsforschung GmbH für das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Jacalin-ähnliches Lectin und Kombinationspräparat zur Verwendung bei der Behandlung oder Prophylaxe von Virusinfektionen in einem Mensch oder Tier

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0309602B1 (de) * 1987-09-30 1993-03-24 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Verwendung katabolischer Enzyme zur Herstellung eines Medikaments zum Bekämpfen der erworbenen Immunschwäche (AIDS) und deren Vorstadien (LAS, ARC)

Also Published As

Publication number Publication date
ATE92331T1 (de) 1993-08-15
DE58905180D1 (de) 1993-09-09
EP0421022B1 (de) 1993-08-04
EP0421022A1 (de) 1991-04-10

Similar Documents

Publication Publication Date Title
WO2002060474A3 (de) Gemische von enzymen aus pilzen und deren verwendung zur behandlung der maldigestion
DE3785036D1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
DE3872398D1 (de) Enzymatische waschmittelzusammensetzung.
BR9607543A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de bis-amino ácido
DE69316501T2 (de) Proteasen zur Inhibierung und Beseitigung von Biofilm
ES2151618T3 (es) Inhibidores de proteasas retrovirales.
BR9607638A (pt) Inibidores de protease retrovirais de hidroxietilamino sulfonamida de aminoácido
BR9607450A (pt) Inibidores de protease retroviral sulfonilalcanoilamino hidroxietilamino sulfonamida
ES2059666T3 (es) Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih.
GR3015924T3 (en) Catabolic enzymes for the induction of the tumour necrosis factor (TNF).
FI956178A (fi) Varsibromelaiiniproteaasin lääkekäyttö
ATE382084T1 (de) Bromelinbestandteil
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
ATE308339T1 (de) Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis
GB8928811D0 (en) An activator for damaged neurocytes for the prevention and treatment of disease
MX9701998A (es) Una nueva combiancion enzimatica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421022

Country of ref document: ES